Liminal BioSciences Inc reports results for the quarter ended in December - Earnings Summary

Liminal BioSciences

22/03/2022 21:01

* Liminal BioSciences Inc  LMNL.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 40 cents per share.
    * Revenue fell 77% to C$238.00 thousand from a year ago. 
    * Liminal BioSciences Inc's reported EPS for the quarter was
a
loss of 31 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Liminal BioSciences Inc shares had fallen by 17.3% this
quarter.
    * The company reported a quarterly loss of C$16.99 million.
    * Wall Street's median 12-month price target for Liminal
BioSciences Inc is $2.30 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 22 at 09:01 p.m.  ​All
figures in Canadian dollars unless otherwise stated